MANKIND

The stock’s underperformance extends beyond the past year, with returns lagging the BSE500 index over the last three years, one year, and three months. This persistent underperformance underscores challenges in sustaining growth momentum and investor confidence. Despite these trends, the company has demonstrated healthy long-term growth in net sales and operating profit, with annualised growth rates of 18.21% and 18.72% respectively. These figures indicate a solid underlying business expansion, albeit not fully reflected in recent stock price movements